An enzyme immunoassay for the diagnosis of syphilis (ELISA-SY) was developed with solid-phase extracts of Treponema pallidum, specimen diluent containing Reiter treponeme absorbent, and three 30-min incubations. The ELISA-SY results were determined in comparison with a standardized positive control and reported as a percentage of strong positive control. In tests with 1,005 serum samples from a venereal disease clinic and other sources, 98.2% agreement was found with fluorescent treponemal antibody-absorption (FTA-ABS) results, and 98.3% agreement was found with T. pallidum passive hemagglutination (PHA) findings. Only 1 of 29 sera originally considered to be biologically false-positive was positive by ELISA-SY; the latter specimen was also positive by PHA and FTA-ABS tests performed in our laboratories. Serum samples from clinically diagnosed syphilitics (16 primary-stage isolates, 7 secondary-stage isolates, and 3 latent-stage isolates) were all positive by ELISA-SY, FTA-ABS, and PHA. Serum samples from 51 newborns suspected of having syphilis on the basis of positive cardiolipin flocculation tests showed 98% agreement of ELISA-SY results with FTA-ABS and PHA findings. Sera from all 61 patients with a variety of autoimmune and other diseases known to be associated with biologically false-positive reactions for syphilis were negative by this ELISA-SY. The specificity of the ELISA procedure for T. pallidum antibody was also confirmed immunologically by blocking experiments.
The serological detection of specific antibodies to Treponema pallidum is of particular importance in the diagnosis of syphilis, since the natural course of this infection is characterized by periods without significant clinical manifestations and the organism cannot be readily cultured in vitro. Although the nontreponemal (cardiolipin) antibody tests are extremely valuable for screening purposes, their relative lack of specificity for syphilis, i.e., treponemal antibody specificity, is a distinct disadvantage. Because of this, more specific serological tests with T. pallidum as antigen have been introduced and are widely used for confirmation of the screening results. Principal armong these are the fluorescent treponemal antibody-absorbent (FTA-ABS) and passive hemagglutination (PHA) methods (9) . In both of these, an extract of a nonpathogenic treponeme (Treponema phagedenis Reiter) is added to each specimen as an absorbent to render the procedures even more specific for T. pallidum antigens (15) .
In recent years, enzyme-linked immunoassays (ELISAs) have proven quite valuable in the diagnosis of a wide variety of infectious and immunological diseases (3, 12, 16) . Several laboratories have applied such procedures to syphilis with considerable success by using T. pallidum extracts as antigen (4, 7, 14, 17, 18) . Our group has developed a series of 16 diagnostic ELISA procedures, all of which use similar reagents and format (5, 6, 10) . The present report describes the results obtained with a rapid simple assay of this type for the detection of antibodies to T. pallidum that incorporates the T. phagedenis Reiter absorbent in the specimen diluent.
MATERIALS AND METHODS
T. pallidum antigens. Washed suspensions of T. pallidium Nichols from 7-to 10-day infected rabbit testes were obtained from Lee laboratories, Grayson, Ga., and stored frozen. When needed, the suspension was thawed and extracted twice with 0.2% sodium deoxycholate in 0.1 M citratebuffered 0.1 M NaCl (pH 7.4) for 1 to 2 h at 4°C. The extracts were clarified by centrifugation, and the protein content was estimated by A280 and A260 (8) . The antigen solutions were stored at -70°C until used.
ELISA reagents. T. pallidum antigen was appropriately diluted in 0.1 M sodium bicarbonate (pH 9.6) and coated overnight at 4°C onto small plastic disks containing isothiocyanate groups (2) . The disks were transferred to 0.1% gelatin and rotated at 4°C for 8 h to block unused binding sites. They were then sequentially washed with phosphatebuffered saline (pH 7.4), 0.01 M sodium bicarbonate buffer (pH 9.6), and finally 0.1% gelatin solution in 0.01 M sodium carbonate before being lyophilized. The dried antigen-coated disks were stored with desiccant at 4°C until use. They were stable for at least 16 months under these conditions.
The (1, 4, 11, 13 (Table 6 ). However, 13 of the 85 specimens tested were positive by a syphilis screening procedure with cardiolipin as antigen (RPR). These 13 therefore represent additional biologically false-positive reactors which were negative by ELISA-SY.
The immunological specificity of the ELISA for syphilis was also confirmed by blocking experiments. Sera phagedenis Reiter sonic extracts, extracts of bovine heart, cytomegalovirus, and Toxoplasma gondii, calf thymus deoxyribonucleoprotein, and calf thymus DNA. The last four antigen preparations had been previously shown to significantly block the ELISAs for antibodies to these antigens by the same format and procedure (5, 6) . Only the T. pallidium extracts significantly blocked the ELISA-SY reactivity (Table 7) .
Reproducibility. Positive sera (four samples; ELISA-SY values of 70, 81, 117, and 178) and negative sera (three samples; ELISA-SY values of 22, 18, and 18) were assayed by ELISA-SY in replicates of six on five different days in one laboratory. In 210 total repeat tests, the four positive serum samples always showed positive results, with coefficients of variation of 9, 11, 5, and 8%. The three negative serum samples always showed negative results, with coefficients of variation of 13, 15, and 14%. The good duplicate reproducibility of 20 serum samples assayed blindly at the CDC is also shown above (Table 3) .
These same seven specimens were coded and assayed by four different operators in four different laboratories in replicates of six for each specimen. In 168 total repeat tests in the four laboratories, all four positive serum samples were positive on every occasion, with coefficients of variation of 8, 6, 9, and 16%. All three negative serum samples were always negative, with coefficients of variation of 14, 7, and 10%. DISCUSSION Serological tests for syphilis play a significant role in the diagnosis of this infection since the organisms cannot yet be readily cultivated in vitro and can be visualized by direct microscopy for only a relatively short time during the course of the prolonged infection. The present ELISA procedure with the Reiter absorbent in the specimen diluent revealed results which were in very good agreement with the two other most widely used treponemal tests for detecting T. pallidum-specific antibodies. Unlike these other procedures (FTA-ABS and PHA), the ELISA-SY does not require any pretreatment of the serum (such as heat inactivation) or parallel testing with uncoated erythrocytes. In addition, the ELISA-SY results are based on objective numerical absorbance readings, whereas the other tests require subjective interpretation. The ELISA-SY results agreed with FTA-ABS findings in 98.2% of the cases and with PHA in 98.3% of the 1,005 specimens assayed by all procedures. Of the 19 discrepancies in the 1,005 specimens, only eight cases were seen in which the ELISA-SY findings disagreed with both of these other methods. It is possible that these discrepancies were caused by differences in the physical form or presentation of the T. palliduim antigen used in the tests or that the subjectivity of readout in the non-ELISA methods was contributory.
The specificity of the ELISA-SY procedure for T. paillidum and syphilis was supported in a number of ways in addition to the very good agreement among all three treponemal test results. Serum samples from 61 patients with a variety of autoimmune and other diseases which are often associated with biologically false-positive cardiolipin screening tests for syphilis were all negative by ELISA-SY. Most of these patients had very high levels of the autoantibodies, etc., associated with their illnesses. In fact, 13 of the 56 serum samples tested (23%) showed positive RPR results, a Blocking antigens were prepared as described elsewhere (5, 6) or by the same procedure as for T. pallidum. NP, Deoxyribonucleoprotein. indicating that they would be considered biologically falsepositive results. In addition, 30 serum samples with extremely high titers to three other microbial agents (Toxoplasma gondii, herpes simplex virus, and cytomegalovirus) were all clearly negative by ELISA-SY. A panel of 29 specimens which were biologically false-positive revealed only 1 which was reactive by ELISA-SY. The same specimen was also reactive by FTA-ABS and PHA in our laboratory. Finally, immunological absorption studies with a number of other antigens, including the Reiter spirochete and extracts of bovine heart, revealed that only T. pallidum extracts were capable of blocking the ELISA-SY reactivity in positive specimens.
Although ELISA tests with T. pallidum extracts were described some time ago (4, 7, 14, 17, 18) , these assays are not yet widely used diagnostically. It has been suggested by Hunter et al. (7) that poor antigen stability may be one factor in this delay. The present ELISA-SY does not suffer from this problem, and the disks, as well as the other reagents, are stable for at least 1 year 4 months when stored appropriately at 2 to 8°C. Other quite similar diagnostic ELISAs which have been developed in our laboratory (5, 6, 10) have revealed documented stability for up to 4 or 5 years.
Many of the sera tested in this study of necessity had been stored for some time prior to assay, mostly frozen. It has been suggested that fresh sera (fewer than 4 days old) stored at 2 to 8°C may give more reliable results in other syphilis serological assays (9) . It is of interest that there were no discrepancies in the three treponemal antibody tests with all 172 serum samples that were assayed within 3 days after collection. Further studies are required to confirm this.
Although a small number of serum samples from individuals with clinically diagnosed syphilis were found to yield satisfactory results with the present ELISA-SY, additional investigations with larger numbers of patients at various stages of the disease are planned.
